Unique ID issued by UMIN | UMIN000038646 |
---|---|
Receipt number | R000044034 |
Scientific Title | The relationship between arterial function and the ability to produce equol in menopausal or postmenopausal women: focused on intestinal microbiome. |
Date of disclosure of the study information | 2019/12/01 |
Last modified on | 2020/09/08 17:47:33 |
The relationship between arterial function and the ability to produce equol in menopausal or postmenopausal women: focused on intestinal microbiome.
The relationship between arterial function and the ability to produce equol in menopausal or postmenopausal women: focused on intestinal microbiome.
The relationship between arterial function and the ability to produce equol in menopausal or postmenopausal women: focused on intestinal microbiome.
The relationship between arterial function and the ability to produce equol in menopausal or postmenopausal women: focused on intestinal microbiome.
Japan |
Healthy adults
Adult |
Others
NO
The purpose of this study is to clarify the relationship between equol production, arterial function, dietary factors, and lifestyle habits in menopausal or postmenopausal women, focusing on the gut microbiota.
Others
Observational study
The objective of this study is to clarify the relationship among arterial function, the ability to produce equol, dietary factors, and lifestyle habits in menopausal or postmenopausal women, focused on intestinal microbiome.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
Food |
Taking foods contained soy isoflavones for 3 days.
40 | years-old | <= |
64 | years-old | >= |
Female
1. Subjects who are menopause period or post-menopause within 5 years (self-assessment information).
2. Subjects whose written informed consent has been obtained by her voluntary participations.
3. Subjects whose do not have serious cerebrovascular disease, heart disease, liver disease, kidney disease, digestive system disease, and infectious disease.
1. Subject who have soy allergies.
2. Subject who have hormone replacement therapy
3. Subject who have the disease that need to have medical treatment, given drugs, receiving general lifestyle guidance, and who are judged as unsuitable for the current study by the principal investigator.
4. Subject who is participating in other clinical trial, or have participated in other clinical trial within 30 days before the informed for consent this study.
5. Subject who is HBV, HCV, or HIV positive in the blood test of this study.
6. Subjects who have been determined ineligible by principal investigator.
50
1st name | Yuko |
Middle name | |
Last name | TOUSEN |
National Institutes of Biomedical Innovation, Health and Nutrition
Department of Food Function and Labeling
162-8636
1-23-1 Toyama, Shinjuku-ku,Tokyo
03-3203-8063
tousen@nibiohn.go.jp
1st name | Yuko |
Middle name | |
Last name | TOUSEN |
National Institutes of Biomedical Innovation, Health and Nutrition
Department of Food Function and Labeling
162-8636
1-23-1 Toyama, Shinjuku-ku, Tokyo
03-3203-8063
tousen@nibiohn.go.jp
National Institutes of Biomedical Innovation, Health and Nutrition
DANON Institute of Japan Foundation
Non profit foundation
Ethical Committee of National Institutes of Biomedical Innovation, Health and Nutrition
7-6-8 Saitoasagi, Ibaraki, Osaka
072-641-9829
irb-office@nibiohn.go.jp
NO
2019 | Year | 12 | Month | 01 | Day |
Unpublished
Suspended
2019 | Year | 08 | Month | 22 | Day |
2019 | Year | 11 | Month | 11 | Day |
2019 | Year | 12 | Month | 01 | Day |
2022 | Year | 03 | Month | 31 | Day |
2019 | Year | 11 | Month | 20 | Day |
2020 | Year | 09 | Month | 08 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044034